Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Authors' response to letter to the editor by Aierken et al. regarding "Sex differences in myocardial infarction care and outcomes: a longitudinal Scottish National Data-Linkage Study".

European journal of preventive cardiology·2025
Same author

Takotsubo syndrome: cognitive behavioural therapy, physical training, and brain function recovery in the BREAKOUT trial.

European heart journal·2025
Same author

Morbidity After Takotsubo Syndrome: A Report From the Scottish Takotsubo Registry.

Annals of internal medicine·2025
Same author

The ESC Working Group on Myocardial Function.

European heart journal·2025
Same author

Sex differences in myocardial infarction care and outcomes: a longitudinal Scottish National Data-Linkage Study.

European journal of preventive cardiology·2024
Same author

Calcineurin signaling promotes takotsubo syndrome.

Nature cardiovascular research·2024

Related Experiment Video

Updated: Jun 7, 2026

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
10:24

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Published on: June 11, 2015

Platelet receptor polymorphisms do not influence Staphylococcus aureus-platelet interactions or infective

Shruti Daga1, James G Shepherd, J Garreth S Callaghan

  • 1Center for Infectious Diseases and The Roslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Chancellor's Building, Edinburgh EH164SB, United Kingdom.

Microbes and Infection
|November 4, 2010
PubMed
Summary

Platelet receptor gene variations (GPIIIa and FcγRIIa) do not affect infective endocarditis development or outcomes. These polymorphisms also do not influence Staphylococcus aureus interactions with platelets in vitro.

More Related Videos

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Related Experiment Videos

Last Updated: Jun 7, 2026

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
10:24

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Published on: June 11, 2015

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Genetics

Background:

  • Infective endocarditis involves bacterium-platelet interactions, leading to cardiac vegetations and increased mortality.
  • Platelet receptors GPIIb/IIIa and FcγRIIa are crucial for pathogen-induced platelet activation.
  • The impact of genetic variations in these receptors on endocarditis pathogenesis is not well understood.

Purpose of the Study:

  • To investigate the association between GPIIIa Pl(A1/A2) and FcγRIIa H131R polymorphisms and infective endocarditis.
  • To determine the influence of these polymorphisms on clinical outcomes in patients with infective endocarditis.
  • To assess the effect of these polymorphisms on Staphylococcus aureus-platelet interactions in vitro.

Main Methods:

  • Genotyping for GPIIIa Pl(A1/A2) and FcγRIIa H131R in healthy volunteers and infective endocarditis patients.
  • Echocardiographic assessment of vegetation characteristics.
  • In vitro studies of Staphylococcus aureus-induced platelet aggregation, activation, and adhesion.

Main Results:

  • Platelet receptor genotype did not correlate with infective endocarditis development, vegetation characteristics, or clinical outcomes (embolism, heart failure, surgery, mortality).
  • Patients with the GPIIIa Pl(A1/A1) genotype showed increased in vivo platelet activation.
  • Neither GPIIIa Pl(A1/A2) nor FcγRIIa H131R genotype affected S. aureus-induced platelet adhesion, activation, or aggregation in vitro.

Conclusions:

  • GPIIIa and FcγRIIa polymorphisms do not appear to influence the clinical course of infective endocarditis.
  • These genetic variations do not alter Staphylococcus aureus-platelet interactions in vitro.
  • Further research may be needed to identify other factors influencing infective endocarditis pathogenesis and outcomes.